Nov 19, 2024
Category
Equity
AUM (Cr.)
3,138.46
Exit Load (%)
0.00
Min Inv Lumpsum
100
Expense Ratio
0.00
Sharpe Ratio
28.36
Beta Ratio
0.00
Fund Manager
Chirag Dagli
Inception Date
Nov 30, 2018
Risk Level
Very High
Investment Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there can be no assurance that the investment objective of the scheme will be realized.